This inventor holds 1 USPTO granted patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Laura DroctovÉ: Innovator in Peptide Research
Introduction
Laura DroctovÉ is a prominent inventor based in Paris, France. She has made significant contributions to the field of peptide research, particularly in the development of vasopressin-2 receptor antagonist peptides. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing scientific knowledge.
Latest Patents
Laura DroctovÉ holds a patent for "Vasopressin-2 Receptor Antagonist Peptides and Uses Thereof." This patent highlights her innovative approach to addressing challenges in the medical field through the use of peptide technology. The patent is a testament to her commitment to research and development in this specialized area.
Career Highlights
Laura is affiliated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, a leading research institution in France. Her role at this esteemed organization allows her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.
Collaborations
Laura DroctovÉ works alongside her colleague Justyna Ciolek, with whom she shares a commitment to advancing peptide research. Their collaboration exemplifies the importance of teamwork in achieving innovative breakthroughs in science.
Conclusion
Laura DroctovÉ is a remarkable inventor whose work in peptide research has the potential to impact various medical applications. Her dedication to innovation and collaboration continues to drive her success in the field.